ACADIA Pharmaceuticals (ACAD)

P/S ratio as of March 2026 (TTM): 3.32

According to ACADIA Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.90. At the end of 2025 the company had a P/S ratio of 4.15.

P/S ratio history for ACADIA Pharmaceuticals from 2004 to 2025

PS ratio at the end of each year

Year	P/S ratio	Change
2025	4.15	40.97%
2024	2.94	-58.39%
2023	7.08	41.98%
2022	4.98	-35.69%
2021	7.75	-59.72%
2020	19.2	-1.79%
2019	19.6	88.49%
2018	10.4	-65.29%
2017	29.9	-85.14%
2016	202	-99.66%
2015	> 1000	126.94%
2014	> 1000	1220.3%
2013	> 1000	2761.2%
2012	69.5	151.89%
2011	27.6	2361.7%
2010	1.12	-85.83%
2009	7.91	-62.42%
2008	21.0	-61.22%
2007	54.3	67.72%
2006	32.4	113.64%
2005	15.1	-38.86%
2004	24.8

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Johnson & Johnson JNJ	6.18	86.00%	🇺🇸 USA
Pfizer PFE	2.47	-25.55%	🇺🇸 USA
Eli Lilly LLY	12.2	265.70%	🇺🇸 USA
Bristol-Myers Squibb BMY	2.49	-25.19%	🇺🇸 USA
Vanda Pharmaceuticals VNDA	1.95	-41.47%	🇺🇸 USA
Adamas Pharmaceuticals ADMS	N/A	N/A	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for ACADIA Pharmaceuticals (ACAD)

P/S ratio as of March 2026 (TTM): 3.32